MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial–Mesenchymal Transition

0
165
Researchers investigate the function of miR-199 on gemcitabine-resistance in pancreatic cancer, as well as the underlying mechanism.
[ACS Omega]

Sorry, but the selected Zotpress account can't be found.

Full ArticleGraphical Abstract